{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:13:15Z","timestamp":1783660395342,"version":"3.55.0"},"reference-count":174,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry oh Health Italy","award":["5xmille"],"award-info":[{"award-number":["5xmille"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Lung cancer remains one of the leading causes of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) representing the most common subtype. Despite major advances in immunotherapy, only a subset of patients benefits from current treatments, highlighting the need to better understand the tumor immune microenvironment (TIME) and the mechanisms underlying immune escape. In this context, extracellular vesicles (EVs) have emerged as key mediators of intercellular communication in lung cancer. This review summarizes the current knowledge on the role of EVs in NSCLC progression and immune regulation. We discuss how EVs contribute to primary tumor growth, dissemination, and pre-metastatic niche formation through the transfer of proteins, metabolites and nucleic acids. Particular attention is given to EV-mediated modulation of immune cells, highlighting their role in both immune suppression and immune activation. Furthermore, we provide an overview of the emerging therapeutic applications of EVs in lung cancer, including their use as drug-delivery systems and immunotherapeutic platforms.<\/jats:p>","DOI":"10.3390\/ph19071023","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:56:55Z","timestamp":1782838615000},"page":"1023","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune Regulation and the Role of Extracellular Vesicles in Non-Small Cell Lung Cancer: Biological Mechanisms and Therapeutic Perspectives"],"prefix":"10.3390","volume":"19","author":[{"given":"Nicole","family":"Ferrario","sequence":"first","affiliation":[{"name":"Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9874-7273","authenticated-orcid":false,"given":"Orazio","family":"Fortunato","sequence":"additional","affiliation":[{"name":"Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7163-0787","authenticated-orcid":false,"given":"Patrizia","family":"Ghidotti","sequence":"additional","affiliation":[{"name":"Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Smolarz, B., Lukasiewicz, H., Samulak, D., Piekarska, E., Kolacinski, R., and Romanowicz, H. (2025). Lung Cancer-Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature). Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26052049"},{"key":"ref_2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/13696998.2026.2623789","article-title":"Economic burden of advanced non-small cell lung cancer (NSCLC): A systematic literature review","volume":"29","author":"Jovanoski","year":"2026","journal-title":"J. Med. Econ."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1183\/13993003.00359-2016","article-title":"Risk factors for lung cancer worldwide","volume":"48","author":"Malhotra","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e32899","DOI":"10.1097\/MD.0000000000032899","article-title":"Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment","volume":"102","author":"Alduais","year":"2023","journal-title":"Medicine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00408-025-00801-x","article-title":"Update 2025: Management of Non-Small-Cell Lung Cancer","volume":"203","author":"Jeon","year":"2025","journal-title":"Lung"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jtho.2024.03.021","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the Classification of Residual Tumor After Resection for the Forthcoming (Ninth) Edition of the TNM Classification of Lung Cancer","volume":"19","author":"Detterbeck","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e068832","DOI":"10.1136\/bmjopen-2022-068832","article-title":"Symptoms and signs of lung cancer prior to diagnosis: Case-control study using electronic health records from ambulatory care within a large US-based tertiary care centre","volume":"13","author":"Prado","year":"2023","journal-title":"BMJ Open"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.18053\/jctres.07.202102.010","article-title":"Recent advances in early stage lung cancer","volume":"7","author":"Luna","year":"2021","journal-title":"J. Clin. Transl. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jtho.2016.11.2221","article-title":"Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Propensity-Matched Analysis","volume":"12","author":"David","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.annonc.2021.08.1994","article-title":"Early and locally advanced non-small-cell lung cancer: An update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy","volume":"32","author":"Remon","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.annonc.2022.12.013","article-title":"Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12935-023-02990-y","article-title":"Recent advances in non-small cell lung cancer targeted therapy; an update review","volume":"23","author":"Araghi","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1200\/EDBK_321483","article-title":"Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Decade of Progress","volume":"41","author":"Shields","year":"2021","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","article-title":"Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways","volume":"19","author":"Kraehenbuehl","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12032-025-02822-1","article-title":"Immune checkpoint inhibitors in cancer therapy: What lies beyond monoclonal antibodies?","volume":"42","author":"Zamani","year":"2025","journal-title":"Med. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Stanley, R., Flanagan, S., Reilly, D.O., Kearney, E., Naidoo, J., and Dowling, C.M. (2023). Immunotherapy through the Lens of Non-Small Cell Lung Cancer. Cancers, 15.","DOI":"10.3390\/cancers15112996"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental Mechanisms of Immune Checkpoint Blockade Therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.18.00149","article-title":"Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer with PD-L1 Tumor Proportion Score of 50% or Greater","volume":"37","author":"Reck","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.21.00174","article-title":"Five-Year Outcomes with Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer with PD-L1 Tumor Proportion Score \u2265 50","volume":"39","author":"Reck","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.21037\/jtd.2017.12.120","article-title":"Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer","volume":"10","author":"Niyongere","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/1759-7714.14271","article-title":"Immunotherapy plus chemotherapy showed superior clinical benefit to chemotherapy alone in advanced NSCLC patients after progression on osimertinib","volume":"13","author":"Long","year":"2022","journal-title":"Thorac. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1200\/JCO.22.01503","article-title":"Five-Year Survival Outcomes with Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227","volume":"41","author":"Brahmer","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2011.38.4032","article-title":"Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB\/IV non-small-cell lung cancer: Results from a randomized, double-blind, multicenter phase II study","volume":"30","author":"Lynch","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104135","DOI":"10.1016\/j.critrevonc.2023.104135","article-title":"Immunotherapy-related biomarkers: Confirmations and uncertainties","volume":"192","author":"Catalano","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Said, S.S., and Ibrahim, W.N. (2023). Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15041143"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"102315","DOI":"10.1016\/j.xcrm.2025.102315","article-title":"Addressing clinical needs in NSCLC immunotherapy: Mechanisms of resistance and promising combination strategies","volume":"6","author":"Kang","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1172\/JCI81135","article-title":"The biology and function of exosomes in cancer","volume":"126","author":"Kalluri","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/JTO.0000000000000551","article-title":"Non-Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy","volume":"10","author":"Carbone","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: Integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming Growth Factor-beta Signaling in Immunity and Cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Carlini, V., Noonan, D.M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., and Albini, A. (2023). The multifaceted nature of IL-10: Regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1161067"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: From molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"117194","DOI":"10.1016\/j.bcp.2025.117194","article-title":"Transforming the \u201ccold\u201d tumors to \u201chot\u201d tumors: Strategies for immune activation","volume":"241","author":"Kong","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Genova, C., Dellepiane, C., Carrega, P., Sommariva, S., Ferlazzo, G., Pronzato, P., Gangemi, R., Filaci, G., Coco, S., and Croce, M. (2021). Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.799455"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e1494677","DOI":"10.1080\/2162402X.2018.1494677","article-title":"Smoker and non-smoker lung adenocarcinoma is characterized by distinct tumor immune microenvironments","volume":"7","author":"Li","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41571-024-00932-9","article-title":"Tumour mutational burden: Clinical utility, challenges and emerging improvements","volume":"21","author":"Budczies","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12967-025-06291-y","article-title":"New insights on anti-tumor immunity of CD8(+) T cells: Cancer stem cells, tumor immune microenvironment and immunotherapy","volume":"23","author":"Lin","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.trecan.2024.07.009","article-title":"CD4(+) T cells in antitumor immunity","volume":"10","author":"Montauti","year":"2024","journal-title":"Trends Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Morcillo-Martin-Romo, P., Valverde-Pozo, J., Ortiz-Bueno, M., Arnone, M., Espinar-Barranco, L., Espinar-Barranco, C., and Garcia-Rubino, M.E. (2025). The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances. Biomedicines, 13.","DOI":"10.3390\/biomedicines13040857"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","article-title":"Roles of macrophages in tumor development: A spatiotemporal perspective","volume":"20","author":"Bied","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41419-025-08180-0","article-title":"The emerging role of dendritic cells in the tumor microenvironment: From antigen presentation to targeted immunotherapy","volume":"16","author":"Xie","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Tan, R., Nie, M., and Long, W. (2022). The role of B cells in cancer development. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.958756"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e1356965","DOI":"10.1080\/2162402X.2017.1356965","article-title":"Tumor-associated neutrophils induce apoptosis of non-activated CD8 T-cells in a TNFalpha and NO-dependent mechanism, promoting a tumor-supportive environment","volume":"6","author":"Michaeli","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-024-01244-9","article-title":"Neutrophils in cancer: From biology to therapy","volume":"22","author":"Koenderman","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.21037\/jtd-2025-1328","article-title":"Unraveling the molecular mechanisms of smoking-associated non-small cell lung cancer: A comprehensive analysis of genetic, therapeutic, and immunological","volume":"18","author":"Li","year":"2026","journal-title":"J. Thorac. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00262-020-02770-x","article-title":"Nicotine exhausts CD8(+) T cells against tumor cells through increasing miR-629-5p to repress IL2RB-mediated granzyme B expression","volume":"70","author":"Cheng","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1465-9921-13-81","article-title":"Cigarette smoke-induced accumulation of lung dendritic cells is interleukin-1alpha-dependent in mice","volume":"13","author":"Botelho","year":"2012","journal-title":"Respir. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e000778","DOI":"10.1136\/jitc-2020-000778","article-title":"M1(hot) tumor-associated macrophages boost tissue-resident memory T cells infiltration and survival in human lung cancer","volume":"8","author":"Mellows","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41586-025-09219-0","article-title":"The mutagenic forces shaping the genomes of lung cancer in never smokers","volume":"644","author":"Zhang","year":"2025","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Madeddu, C., Donisi, C., Liscia, N., Lai, E., Scartozzi, M., and Maccio, A. (2022). EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126489"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/cbin.11524","article-title":"KRAS G12V mutation upregulates PD-L1 expression via TGF-beta\/EMT signaling pathway in human non-small-cell lung cancer","volume":"45","author":"Pan","year":"2021","journal-title":"Cell Biol. Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1038\/s41467-025-63465-4","article-title":"Oncogenic driver mutations underlie the spatial tumour immune landscape of non-small cell lung cancer","volume":"16","author":"Hartner","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/1078-0432.CCR-20-3054","article-title":"Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?","volume":"27","author":"Strickler","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"101788","DOI":"10.1016\/j.tranon.2023.101788","article-title":"Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies","volume":"38","author":"Vryza","year":"2023","journal-title":"Transl. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41698-024-00548-3","article-title":"Immune microenvironment heterogeneity of concurrent adenocarcinoma and squamous cell carcinoma in multiple primary lung cancers","volume":"8","author":"Zhang","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41392-022-01130-8","article-title":"The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"16246","DOI":"10.1038\/s41598-024-64980-y","article-title":"The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancer","volume":"14","author":"Weng","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41590-021-00899-0","article-title":"Extracellular vesicles in immunomodulation and tumor progression","volume":"22","author":"Marar","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e12404","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Doyle, L.M., and Wang, M.Z. (2019). Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis. Cells, 8.","DOI":"10.3390\/cells8070727"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1165\/rcmb.2003-0238OC","article-title":"Proteomic analysis of exosomes isolated from human malignant pleural effusions","volume":"31","author":"Bard","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7309","DOI":"10.4049\/jimmunol.166.12.7309","article-title":"Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles","volume":"166","author":"Thery","year":"2001","journal-title":"J. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.biochi.2006.10.014","article-title":"Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies","volume":"89","author":"Subra","year":"2007","journal-title":"Biochimie"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-022-00763-8","article-title":"The roles of extracellular vesicles in the immune system","volume":"23","author":"Buzas","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Alhumaydhi, F.A., and Anwar, S. (2026). Extracellular Vesicles in Cancer: Mechanistic Insights and Clinical Applications. Cancers, 18.","DOI":"10.3390\/cancers18030537"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/bies.201200045","article-title":"Amedeo Avogadro\u2019s cry: What is 1 microg of exosomes?","volume":"34","author":"Sverdlov","year":"2012","journal-title":"Bioessays"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1286095","DOI":"10.1080\/20013078.2017.1286095","article-title":"Obstacles and opportunities in the functional analysis of extracellular vesicle RNA\u2014An ISEV position paper","volume":"6","author":"Mateescu","year":"2017","journal-title":"J. Extracell. Vesicles"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.21873\/anticanres.15874","article-title":"Extracellular Vesicles from EGFR T790M\/L858R-mutant Non-small Cell Lung Cancer Promote Cancer Progression","volume":"42","author":"Janpipatkul","year":"2022","journal-title":"Anticancer. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41419-019-2003-5","article-title":"c-Myc shuttled by tumour-derived extracellular vesicles promotes lung bronchial cell proliferation through miR-19b and miR-92a","volume":"10","author":"Borzi","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12964-021-00787-y","article-title":"Extracellular vesicles: Mediators of intercellular communication in tissue injury and disease","volume":"19","author":"Bunn","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-025-02233-w","article-title":"Extracellular vesicles in tumor immunity: Mechanisms and novel insights","volume":"24","author":"Kuang","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Bandini, S., Ulivi, P., and Rossi, T. (2024). Extracellular Vesicles, Circulating Tumor Cells, and Immune Checkpoint Inhibitors: Hints and Promises. Cells, 13.","DOI":"10.3390\/cells13040337"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-021-01490-9","article-title":"Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma","volume":"21","author":"Serrati","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Kielbowski, K., Plewa, P., Szulc, J., Cmil, M., Bakinowska, E., and Pawlik, A. (2025). Extracellular Vesicles and PD-L1-A Review of Complex Immunoregulatory Properties and Clinical Importance. Biomedicines, 13.","DOI":"10.3390\/biomedicines13061356"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Yin, Z., Fan, J., Xu, J., Wu, F., Li, Y., Zhou, M., Liao, T., Duan, L., Wang, S., and Geng, W. (2020). Immunoregulatory Roles of Extracellular Vesicles and Associated Therapeutic Applications in Lung Cancer. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.02024"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10555-025-10287-x","article-title":"Integrins from extracellular vesicles as players in tumor microenvironment and metastasis","volume":"44","author":"Ciobanasu","year":"2025","journal-title":"Cancer Metastasis Rev."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Sagini, K., Costanzi, E., Emiliani, C., Buratta, S., and Urbanelli, L. (2018). Extracellular Vesicles as Conveyors of Membrane-Derived Bioactive Lipids in Immune System. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041227"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","article-title":"Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake","volume":"36","author":"Abels","year":"2016","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.trecan.2023.08.006","article-title":"Extracellular vesicle lipids in cancer immunoevasion","volume":"9","author":"Chen","year":"2023","journal-title":"Trends Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1901779","DOI":"10.1002\/advs.201901779","article-title":"Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy","volume":"6","author":"Xie","year":"2019","journal-title":"Adv. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e1413","DOI":"10.1002\/wrna.1413","article-title":"RNA in extracellular vesicles","volume":"8","author":"Kim","year":"2017","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"59","DOI":"10.20517\/evcna.2022.42","article-title":"Immunomodulatory role of EV-derived non-coding RNA in lung cancer","volume":"4","author":"Ghidotti","year":"2023","journal-title":"Extracell. Vesicles Circ. Nucl. Acids"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1111\/jcmm.13657","article-title":"The miR-3127-5p\/p-STAT3 axis up-regulates PD-L1 inducing chemoresistance in non-small-cell lung cancer","volume":"22","author":"Tang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","article-title":"The role of extracellular vesicles in cancer","volume":"186","author":"Kalluri","year":"2023","journal-title":"Cell"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e109288","DOI":"10.15252\/embj.2021109288","article-title":"Extracellular vesicles and particles impact the systemic landscape of cancer","volume":"41","author":"Lucotti","year":"2022","journal-title":"EMBO J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41598-022-04940-6","article-title":"Extracellular vesicles released by non-small cell lung cancer cells drive invasion and permeability in non-tumorigenic lung epithelial cells","volume":"12","author":"Hasan","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_99","first-page":"1711","article-title":"Cancer cell-derived exosomes promote cell proliferation and inhibit cell apoptosis of both normal lung fibroblasts and non-small cell lung cancer cell through delivering alpha-smooth muscle actin","volume":"11","author":"Huang","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.omto.2019.08.001","article-title":"Exosomal Leucine-Rich-Alpha2-Glycoprotein 1 Derived from Non-Small-Cell Lung Cancer Cells Promotes Angiogenesis via TGF-beta Signal Pathway","volume":"14","author":"Li","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/mc.22935","article-title":"Extracellular vesicle secretion of miR-142-3p from lung adenocarcinoma cells induces tumor promoting changes in the stroma through cell-cell communication","volume":"58","author":"Lawson","year":"2019","journal-title":"Mol. Carcinog."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1038\/onc.2017.105","article-title":"Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1","volume":"36","author":"Hsu","year":"2017","journal-title":"Oncogene"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.7150\/ijbs.31605","article-title":"Extracellular Vesicles (EVs) from Lung Adenocarcinoma Cells Promote Human Umbilical Vein Endothelial Cell (HUVEC) Angiogenesis through Yes Kinase-associated Protein (YAP) Transport","volume":"15","author":"Wang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41388-019-1024-y","article-title":"Bone-marrow-derived cell-released extracellular vesicle miR-92a regulates hepatic pre-metastatic niche in lung cancer","volume":"39","author":"Hsu","year":"2020","journal-title":"Oncogene"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1038\/s41467-018-07339-y","article-title":"Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels","volume":"9","author":"Novo","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1158\/0008-5472.CAN-12-0925","article-title":"Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression","volume":"72","author":"Bobrie","year":"2012","journal-title":"Cancer Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1158\/0008-5472.CAN-16-0868","article-title":"The Biodistribution and Immune Suppressive Effects of Breast Cancer-Derived Exosomes","volume":"76","author":"Wen","year":"2016","journal-title":"Cancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1111\/jcmm.15411","article-title":"Tumour-derived exosomal miR-3473b promotes lung tumour cell intrapulmonary colonization by activating the nuclear factor-kappaB of local fibroblasts","volume":"24","author":"Du","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41419-021-04037-4","article-title":"Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP\/KLF2 in non-small cell lung cancer","volume":"12","author":"Ma","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1038\/s41467-018-07810-w","article-title":"Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis","volume":"9","author":"Zeng","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","article-title":"Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis","volume":"25","author":"Zhou","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/onc.2016.353","article-title":"Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells","volume":"36","author":"Richards","year":"2017","journal-title":"Oncogene"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1007\/s00268-020-05630-y","article-title":"Levels of Extracellular Vesicles in Pulmonary and Peripheral Blood Correlate with Stages of Lung Cancer Patients","volume":"44","author":"Choi","year":"2020","journal-title":"World J. Surg."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/1878-0261.12976","article-title":"Unveiling mutational dynamics in non-small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA","volume":"15","author":"Pasini","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-018-0772-6","article-title":"Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patients","volume":"17","author":"Hur","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"Joyce","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12964-020-00535-8","article-title":"Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma","volume":"18","author":"Xie","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/s41467-018-04695-7","article-title":"Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface","volume":"9","author":"Tang","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: Organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1002\/ijc.32064","article-title":"RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes","volume":"144","author":"Guo","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","article-title":"Pre-metastatic niche: Formation, characteristics and therapeutic implication","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Aiello","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2016.09.013","article-title":"Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers","volume":"384","author":"Regondi","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2022.01.002","article-title":"ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression","volume":"57","author":"Zhang","year":"2022","journal-title":"Dev. Cell"},{"key":"ref_129","first-page":"1","article-title":"Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer","volume":"51","author":"Kim","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"eaar2766","DOI":"10.1126\/sciadv.aar2766","article-title":"Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles","volume":"4","author":"Ricklefs","year":"2018","journal-title":"Sci. Adv."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"16405","DOI":"10.1002\/cam4.6275","article-title":"Prostate cancer cells synergistically defend against CD8(+) T cells by secreting exosomal PD-L1","volume":"12","author":"Li","year":"2023","journal-title":"Cancer Med."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Signorelli, D., Ghidotti, P., Proto, C., Brambilla, M., De Toma, A., Ferrara, R., Galli, G., Ganzinelli, M., Lo Russo, G., and Prelaj, A. (2022). Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.987639"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.4081\/ejh.2023.3784","article-title":"Tumor cells-derived exosomal PD-L1 promotes the growth and invasion of lung cancer cells in vitro via mediating macrophages M2 polarization","volume":"67","author":"Lu","year":"2023","journal-title":"Eur. J. Histochem."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"12834","DOI":"10.1080\/21655979.2022.2076388","article-title":"Knockdown of lncRNA PCAT6 suppresses the growth of non-small cell lung cancer cells by inhibiting macrophages M2 polarization via miR-326\/KLF1 axis","volume":"13","author":"Chen","year":"2022","journal-title":"Bioengineered"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ymthe.2017.11.016","article-title":"Hypoxic Lung-Cancer-Derived Extracellular Vesicle MicroRNA-103a Increases the Oncogenic Effects of Macrophages by Targeting PTEN","volume":"26","author":"Hsu","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13046-019-1027-0","article-title":"Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery","volume":"38","author":"Ren","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Chang, W.A., Tsai, M.J., Hung, J.Y., Wu, K.L., Tsai, Y.M., Huang, Y.C., Chang, C.Y., Tsai, P.H., and Hsu, Y.L. (2021). miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells. Cancers, 13.","DOI":"10.3390\/cancers13246252"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e1062968","DOI":"10.1080\/2162402X.2015.1062968","article-title":"Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-beta and miR23a transfer","volume":"5","author":"Berchem","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.4049\/jimmunol.180.11.7249","article-title":"Human tumor-derived exosomes down-modulate NKG2D expression","volume":"180","author":"Clayton","year":"2008","journal-title":"J. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3324\/haematol.2010.039743","article-title":"Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1","volume":"96","author":"Szczepanski","year":"2011","journal-title":"Haematologica"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Zhao, J., Schlosser, H.A., Wang, Z., Qin, J., Li, J., Popp, F., Popp, M.C., Alakus, H., Chon, S.H., and Hansen, H.P. (2019). Tumor-Derived Extracellular Vesicles Inhibit Natural Killer Cell Function in Pancreatic Cancer. Cancers, 11.","DOI":"10.3390\/cancers11060874"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1186\/s12967-024-05457-4","article-title":"Extracellular vesicles at the crossroad between cancer progression and immunotherapy: Focus on dendritic cells","volume":"22","author":"Schioppa","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.imlet.2018.05.002","article-title":"Tumor exosomes block dendritic cells maturation to decrease the T cell immune response","volume":"199","author":"Ning","year":"2018","journal-title":"Immunol. Lett."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"18534","DOI":"10.1038\/s41598-021-97753-y","article-title":"Extracellular vesicles cargo from head and neck cancer cell lines disrupt dendritic cells function and match plasma microRNAs","volume":"11","author":"Marti","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41419-020-03042-3","article-title":"Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1368823","DOI":"10.1080\/20013078.2017.1368823","article-title":"Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes","volume":"6","author":"Salimu","year":"2017","journal-title":"J. Extracell. Vesicles"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Grange, C., Tapparo, M., Tritta, S., Deregibus, M.C., Battaglia, A., Gontero, P., Frea, B., and Camussi, G. (2015). Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-2025-z"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/2326-6066.CIR-14-0177","article-title":"Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS\/STING signaling","volume":"3","author":"Zhang","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.7150\/thno.43539","article-title":"Radiation-induced small extracellular vesicles as \u201ccarriages\u201d promote tumor antigen release and trigger antitumor immunity","volume":"10","author":"Lin","year":"2020","journal-title":"Theranostics"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1158\/2326-6066.CIR-13-0112-T","article-title":"Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing","volume":"2","author":"Rughetti","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jhep.2017.05.019","article-title":"Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models","volume":"67","author":"Lu","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2005-01-0220","article-title":"ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming","volume":"106","author":"Segura","year":"2005","journal-title":"Blood"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"e1219827","DOI":"10.1080\/2162402X.2016.1219827","article-title":"RIG-I activation induces the release of extracellular vesicles with antitumor activity","volume":"5","author":"Reiners","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e1279372","DOI":"10.1080\/2162402X.2017.1279372","article-title":"Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70\/TLR2\/NF-kB axis","volume":"6","author":"Vulpis","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.1101988","article-title":"Immune surveillance properties of human NK cell-derived exosomes","volume":"189","author":"Lugini","year":"2012","journal-title":"J. Immunol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.7150\/thno.18752","article-title":"Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma","volume":"7","author":"Zhu","year":"2017","journal-title":"Theranostics"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00262-019-02459-w","article-title":"Lung cancer-derived extracellular vesicles: A possible mediator of mast cell activation in the tumor microenvironment","volume":"69","author":"Salamon","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2217\/nnm-2019-0431","article-title":"Characterization and antiproliferative activity of glioma-derived extracellular vesicles","volume":"15","author":"Scholl","year":"2020","journal-title":"Nanomedicine"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Coward-Smith, M., Zakarya, R., Oliver, B.G., Kim, R.Y., and Donovan, C. (2025). Extracellular vesicles in pulmonary diseases: Roles and therapeutic potential. BMC Pulm. Med., 25.","DOI":"10.1186\/s12890-025-03965-7"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12935-022-02743-3","article-title":"Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy","volume":"22","author":"Hussen","year":"2022","journal-title":"Cancer Cell Int."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s41571-025-01074-2","article-title":"Clinical relevance of extracellular vesicles in cancer\u2014Therapeutic and diagnostic potential","volume":"22","author":"Greening","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Carreca, A.P., Tinnirello, R., Miceli, V., Galvano, A., Gristina, V., Incorvaia, L., Pampalone, M., Taverna, S., and Iannolo, G. (2024). Extracellular Vesicles in Lung Cancer: Implementation in Diagnosis and Therapeutic Perspectives. Cancers, 16.","DOI":"10.3390\/cancers16111967"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"e1071008","DOI":"10.1080\/2162402X.2015.1071008","article-title":"Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC","volume":"5","author":"Besse","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41565-023-01580-3","article-title":"Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity","volume":"19","author":"Liu","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1021\/acsbiomaterials.5c00434","article-title":"Engineered Extracellular Vesicles for Tumor-Targeted Delivery of Therapeutic siRNA for Lung Cancer Therapy","volume":"11","author":"Asfiya","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2015.10.020","article-title":"Bovine milk-derived exosomes for drug delivery","volume":"371","author":"Munagala","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.nano.2017.03.001","article-title":"Milk-derived exosomes for oral delivery of paclitaxel","volume":"13","author":"Agrawal","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"e12508","DOI":"10.1002\/jev2.12508","article-title":"Scalable production of siRNA-encapsulated extracellular vesicles for the inhibition of KRAS-mutant cancer using acoustic shock waves","volume":"13","author":"Kim","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Gaurav, I., Thakur, A., Zhang, K., Thakur, S., Hu, X., Xu, Z., Kumar, G., Jaganathan, R., Iyaswamy, A., and Li, M. (2024). Peptide-Conjugated Vascular Endothelial Extracellular Vesicles Encapsulating Vinorelbine for Lung Cancer Targeted Therapeutics. Nanomaterials, 14.","DOI":"10.3390\/nano14201669"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12967-023-04206-3","article-title":"Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer","volume":"21","author":"Zheng","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"216960","DOI":"10.1016\/j.canlet.2024.216960","article-title":"Revisiting the advances and challenges in the clinical applications of extracellular vesicles in cancer","volume":"593","author":"He","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/10408363.2024.2309935","article-title":"Extracellular vesicles in cancer: Challenges and opportunities for clinical laboratories","volume":"61","author":"Gonzalez","year":"2024","journal-title":"Crit. Rev. Clin. Lab. Sci."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/7\/1023\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:17:18Z","timestamp":1783657038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/7\/1023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":174,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ph19071023"],"URL":"https:\/\/doi.org\/10.3390\/ph19071023","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]}}}